FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4041511000001100: Lansoprazole 30mg orodispersible gastro-resistant tablets 14 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21903701000001115 Lansoprazole 30mg orodispersible gastro-resistant tablets 14 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
38329401000001117 Lansoprazole 30mg orodispersible tablets 14 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lansoprazole 30mg orodispersible gastro-resistant tablets 14 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lansoprazole 30mg orodispersible gastro-resistant tablets 14 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Lansoprazole 30mg orodispersible gastro-resistant tablets 14 tablet Is pack of Lansoprazole 30mg orodispersible gastro-resistant tablets false Inferred relationship Existential restriction modifier
Lansoprazole 30mg orodispersible gastro-resistant tablets 14 tablet Has active ingredient Lansoprazole false Inferred relationship Existential restriction modifier
Lansoprazole 30mg orodispersible gastro-resistant tablets 14 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lansoprazole 30mg orodispersible gastro-resistant tablets 14 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lansoprazole 30mg orodispersible gastro-resistant tablets 14 tablet Has manufactured dose form Conventional release oral lyophilisate false Inferred relationship Existential restriction modifier
Lansoprazole 30mg orodispersible gastro-resistant tablets 14 tablet Has VMP Lansoprazole 30mg orodispersible gastro-resistant tablets true Inferred relationship Existential restriction modifier
Lansoprazole 30mg orodispersible gastro-resistant tablets 14 tablet Has specific active ingredient Lansoprazole true Inferred relationship Existential restriction modifier
Lansoprazole 30mg orodispersible gastro-resistant tablets 14 tablet Has dispensed dose form Orodispersible tablet false Inferred relationship Existential restriction modifier
Lansoprazole 30mg orodispersible gastro-resistant tablets 14 tablet Has dispensed dose form Conventional release orodispersible tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Zoton FasTab 30mg orodispersible gastro-resistant tablets (Wyeth Laboratories) 14 tablet 2 x 7 tablets Is a True Lansoprazole 30mg orodispersible gastro-resistant tablets 14 tablet Inferred relationship Existential restriction modifier
Zoton FasTab 30mg (Doncaster Pharmaceuticals Ltd) 14 tablet Is a True Lansoprazole 30mg orodispersible gastro-resistant tablets 14 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start